MY106271A - Cyclosporin ophthalmic compositions. - Google Patents

Cyclosporin ophthalmic compositions.

Info

Publication number
MY106271A
MY106271A MYPI89001487A MYPI19891487A MY106271A MY 106271 A MY106271 A MY 106271A MY PI89001487 A MYPI89001487 A MY PI89001487A MY PI19891487 A MYPI19891487 A MY PI19891487A MY 106271 A MY106271 A MY 106271A
Authority
MY
Malaysia
Prior art keywords
ophthalmic compositions
compositions
cyclosporin
tissues
eye
Prior art date
Application number
MYPI89001487A
Other languages
English (en)
Inventor
Ronald Edward Peeples Dr
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY106271A publication Critical patent/MY106271A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
MYPI89001487A 1988-10-26 1989-10-26 Cyclosporin ophthalmic compositions. MY106271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
MY106271A true MY106271A (en) 1995-04-29

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001487A MY106271A (en) 1988-10-26 1989-10-26 Cyclosporin ophthalmic compositions.

Country Status (23)

Country Link
JP (1) JPH02164830A (fr)
KR (1) KR900005973A (fr)
AU (1) AU626928B2 (fr)
BE (1) BE1003578A4 (fr)
CA (1) CA2001502A1 (fr)
CH (1) CH679210A5 (fr)
DE (1) DE3935517A1 (fr)
DK (1) DK531289A (fr)
ES (1) ES2020032A6 (fr)
FI (1) FI895064A7 (fr)
FR (1) FR2638089A1 (fr)
GB (1) GB2224205B (fr)
GR (1) GR1000611B (fr)
HU (1) HU203046B (fr)
IL (1) IL92120A (fr)
LU (1) LU87613A1 (fr)
MY (1) MY106271A (fr)
NL (1) NL8902657A (fr)
NO (1) NO894266L (fr)
NZ (1) NZ231131A (fr)
PT (1) PT92120B (fr)
SE (1) SE8903583L (fr)
ZA (1) ZA898140B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (fr) * 1988-11-07 1990-05-07 Shuichi Morikawa Procede de production de fibres polyimides
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
JP2011502990A (ja) * 2007-11-05 2011-01-27 ボーシュ アンド ローム インコーポレイティド 薬物送達用ビヒクルとしての水非混和性物質
PL2437762T3 (pl) * 2009-06-05 2018-01-31 Allergan Inc Sztuczne łzy i ich zastosowania terapeutyczne
CA2967413C (fr) 2014-11-25 2023-08-15 Allergan, Inc. Compositions ophtalmiques contenant des huiles d'omega-3 stabilisees pardes antioxydants
DK3399962T3 (da) 2016-12-23 2020-09-07 Novaliq Gmbh Oftalmisk sammensætning til behandling af tør øjensygdom
WO2021044045A1 (fr) * 2019-09-06 2021-03-11 Novaliq Gmbh Composition ophtalmique pour le traitement de l'uvéite
EP4201398A1 (fr) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin de pour le traitement topique de maladies oculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
AU4371589A (en) 1990-05-03
ES2020032A6 (es) 1991-07-16
GB8924040D0 (en) 1989-12-13
SE8903583L (sv) 1990-04-27
CA2001502A1 (fr) 1990-04-26
HU895444D0 (en) 1990-01-28
KR900005973A (ko) 1990-05-07
LU87613A1 (fr) 1991-05-07
CH679210A5 (fr) 1992-01-15
FR2638089A1 (fr) 1990-04-27
IL92120A0 (en) 1990-07-12
FI895064A7 (fi) 1990-04-27
NO894266L (no) 1990-04-27
ZA898140B (en) 1991-06-26
NL8902657A (nl) 1990-05-16
SE8903583D0 (sv) 1989-10-26
DE3935517A1 (de) 1990-05-03
IL92120A (en) 1994-02-27
DK531289A (da) 1990-04-27
HU203046B (en) 1991-05-28
BE1003578A4 (fr) 1992-04-28
JPH02164830A (ja) 1990-06-25
FI895064A0 (fi) 1989-10-25
NO894266D0 (no) 1989-10-26
GB2224205A (en) 1990-05-02
DK531289D0 (da) 1989-10-25
GR890100690A (en) 1990-11-29
PT92120A (pt) 1990-04-30
GB2224205B (en) 1992-04-15
GR1000611B (el) 1992-08-31
NZ231131A (en) 1992-06-25
AU626928B2 (en) 1992-08-13
HUT52394A (en) 1990-07-28
PT92120B (pt) 1995-06-30

Similar Documents

Publication Publication Date Title
MY106271A (en) Cyclosporin ophthalmic compositions.
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
AU4686689A (en) Biocidal compositions
CA2201310A1 (fr) Extraits antineoplasiques de cacao et leurs procedes de preparation et d'utilisation
WO2003051294A3 (fr) Compositions acaricides et methodes associees
IL107207A0 (en) Sustained release pharmaceutical compositions
ES2095926T3 (es) Cyclosporins.
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
CA2223510A1 (fr) Intercepteurs catalytiques synthetiques de radicaux libres s'utilisant comme antioxydants dans la prevention et le traitement de maladies
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
CA2172513A1 (fr) Aminocyclohexylesters et leurs utilisations
AU4312285A (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
CA2011637A1 (fr) Composes pour la liberation soutenue de chlorhexidine
CA2177683A1 (fr) Compositions anti-microbiennes d'humidification des tissus
ATE151640T1 (de) Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
CA2190505A1 (fr) Utilisation de formulations se presentant sous forme de gel comme agents desinfectants
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
ATE319458T1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
CA2140361A1 (fr) Composition et methodes pour diminuer l'affaissement musculaire
FR2753371B1 (fr) Utilisation d'un extrait de la plante terminalia catappa et compositions cosmetique dermatologique et pharmaceutique comportant un tel extrait
DE69728536D1 (de) Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis
WO1995016435A3 (fr) Solution d'irrigation intraoculaire amelioree contenat un agent anti-inflammatoire non-steroidien
CA2340734A1 (fr) Derive de pyridyl-4h-1,2,4-oxadiazine optiquement actif et son utilisation dans le traitement des maladies vasculaires
EP0373771A3 (fr) Nouvelles utilisations pharmaceutiques des cystatines